Armata Pharmaceuticals (ARMP) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -494.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -649.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4,853.00 |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 1,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,958.00 |
| Dec 31, 2025 | 383.00 |
| Sep 30, 2025 | 9,719.00 |
| Jun 30, 2025 | 12,908.00 |
| Mar 31, 2025 | 20,340.00 |
| Dec 31, 2024 | -4,991.00 |
| Sep 30, 2024 | 33,806.00 |
| Jun 30, 2024 | 52,849.00 |
| Mar 31, 2024 | 585,554.00 |
| Dec 31, 2023 | 1,426.00 |
| Sep 30, 2023 | -75.00 |
| Jun 30, 2023 | -2,502.00 |
| Mar 31, 2023 | -294.00 |
| Dec 31, 2022 | 3,462.00 |
| Sep 30, 2022 | 3,061.00 |
| Jun 30, 2022 | 5,198.00 |
| Mar 31, 2022 | 10,263.00 |
| Dec 31, 2021 | 5,907.00 |
| Sep 30, 2021 | 6,260.00 |
| Jun 30, 2021 | 2,874.00 |
| Mar 31, 2021 | 9,055.00 |
| Dec 31, 2020 | 9,384.00 |
| Sep 30, 2020 | 16,621.00 |
| Jun 30, 2020 | 20,788.00 |
| Mar 31, 2020 | 9,171.00 |
| Dec 31, 2019 | 3,819.00 |
| Sep 30, 2019 | -795.00 |
| Jun 30, 2019 | -3,015.00 |
| Mar 31, 2019 | -8,970.00 |
| Dec 31, 2018 | -7,177.00 |
| Sep 30, 2018 | -9,285.00 |
| Jun 30, 2018 | -4,590.00 |
| Mar 31, 2018 | -10,023.00 |
| Dec 31, 2017 | -10,432.00 |
| Sep 30, 2017 | -16,860.00 |
| Jun 30, 2017 | -22,502.00 |
| Mar 31, 2017 | -13,100.00 |